Article info

Download PDFPDF
Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?

Authors

  1. Address correspondence and reprint requests to Karin Leunen, MD, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. E-mail: karin.leunen{at}uz.kuleuven.ac.be.

Citation

Leunen K, Cadron I, Van Gorp T, et al
Does Paclitaxel-Carboplatin Chemotherapy in a Dose-Dense Regimen Enhance Survival of BRCA-Related Ovarian Cancer Patients?

Publication history

  • Received March 25, 2009
  • First published November 1, 2009.
Online issue publication 
November 01, 2009

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.